Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The recruitment notice now states that no participants are being sought, signaling that enrollment for the study has ended. A new revision tag (v3.6.0) was added to the record to capture this update in the study history.
    Difference
    0.2%
    Check dated 2026-06-12T17:18:37.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The history now shows the latest revision as v3.5.5, with the prior v3.5.4 removed. This reflects an update to the record's revision history rather than a change to trial content.
    Difference
    0.1%
    Check dated 2026-06-05T16:58:30.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the history; the previous revision v3.5.3 was removed. This indicates a minor update to the page's version history rather than substantive changes to study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:45.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page’s footer shows an updated ClinicalTrials.gov revision from v3.5.2 to v3.5.3, indicating a software/version update rather than any substantive modification to the study’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T06:30:42.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:11.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T08:33:18.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.